Ipratropium Bromide
39 NDCs across 16 manufacturers|38 Generic,1 Brand
Ipratropium Bromide is used to treat bronchial spasm, bronchitis, pulmonary emphysema, rhinitis, allergic, perennial and vasomotor rhinitis, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved on Dec 29, 1986, and the first generic was approved Jan 10, 1997. FDA's Orange Book lists 14 AB-rated (therapeutically equivalent) products for this ingredient. In 2024, Medicare Part D spent $180 million on Ipratropium Bromide across 2.3 million claims for 928,000 beneficiaries.
Ipratropium Bromide is available as 39 NDCs from 16 manufacturers (38 generic, 1 brand), with NADAC prices from $0.05 to $0.87 per ML — the most expensive product costs about 16× the cheapest. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
39
38G / 1B
Manufacturers
16
competing in market
Price Spread
$0.05 – $0.87
per ML, 38 of 39 NDCs
7d Activity
avg -0.7% WoW · of 39 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Explore this market from other angles
Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.
Top supplier
Nephron Pharmaceuticals Corporation manufacturer profile
Open the supplier page for the manufacturer with the strongest footprint in this market.
Lead class
Anticholinergic class view
See how this market rolls up into the broader therapeutic class and compare other drugs in the same bucket.
Trend hub
Latest market trends
Move from this single molecule into the current cross-market mover and volatility view.
Guide
How to interpret NADAC
Review the benchmark methodology behind the prices and spreads shown on this market page.
Manufacturer Breakdown
16 manufacturers producing IPRATROPIUM BROMIDE(1 pricing outlier)
Frequently Asked Questions
What is Ipratropium Bromide used to treat?
Ipratropium Bromide is used to treat bronchial spasm, bronchitis, pulmonary emphysema, rhinitis, allergic, perennial and vasomotor rhinitis, per the National Library of Medicine's MED-RT classification.
When did Ipratropium Bromide become available as a generic?
FDA approved the first generic Ipratropium Bromide (ANDA) on Jan 10, 1997. The Orange Book currently lists 14 AB-rated products for this ingredient, meaning FDA considers them therapeutically equivalent to the brand.
How much does Medicare spend on Ipratropium Bromide?
In 2024, Medicare Part D spent $180 million on Ipratropium Bromide across 2.3 million claims for 928,000 beneficiaries.
How many Ipratropium Bromide products are on the market?
The Ipratropium Bromide drug market contains 39 NDCs from 16 manufacturers — 38 generic and 1 brand product.
What is the price range for Ipratropium Bromide?
NADAC reference prices for Ipratropium Bromide range from $0.0529 to $0.8711 per ML — the most expensive product costs about 16× the cheapest. 1 additional product is priced per a different unit (e.g. liquids per ML) and isn't directly comparable.
Which manufacturers make Ipratropium Bromide?
16 manufacturers list Ipratropium Bromide in NADAC. Ranked by number of NDCs, the largest are Nephron Pharmaceuticals Corporation (5), Mylan Pharmaceuticals Inc. (4), Ritedose Pharmaceuticals, LLC (4), Aurobindo Pharma Limited (3), Rising Pharma Holdings Inc. (3).
How has the price of Ipratropium Bromide changed recently?
Over the past 7 days, 11 Ipratropium Bromide NDCs rose and 18 fell, with a market-wide average change of -0.7%.